[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 67, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 42, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen J.D.", "age": 53, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.838, "open": 0.8528, "dayLow": 0.7336, "dayHigh": 0.878, "regularMarketPreviousClose": 0.838, "regularMarketOpen": 0.8528, "regularMarketDayLow": 0.7336, "regularMarketDayHigh": 0.878, "payoutRatio": 0.0, "beta": 0.254, "forwardPE": -0.7426733, "volume": 433396, "regularMarketVolume": 433396, "averageVolume": 272842, "averageVolume10days": 256070, "averageDailyVolume10Day": 256070, "bid": 0.602, "ask": 0.96, "bidSize": 2, "askSize": 2, "marketCap": 44108732, "fiftyTwoWeekLow": 0.7336, "fiftyTwoWeekHigh": 7.47, "priceToSalesTrailing12Months": 42.907326, "fiftyDayAverage": 1.30356, "twoHundredDayAverage": 1.92707, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 31652236, "profitMargins": 0.0, "floatShares": 20849814, "sharesOutstanding": 33570300, "sharesShort": 2341795, "sharesShortPriorMonth": 2340699, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0698, "heldPercentInsiders": 0.27793, "heldPercentInstitutions": 0.11079001, "shortRatio": 13.25, "shortPercentOfFloat": 0.0986, "impliedSharesOutstanding": 58803800, "bookValue": 0.06, "priceToBook": 12.501667, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30018000, "trailingEps": -1.05, "forwardEps": -1.01, "enterpriseToRevenue": 30.79, "enterpriseToEbitda": -0.652, "52WeekChange": -0.8764012, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 0.7501, "targetHighPrice": 14.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 27639000, "totalCashPerShare": 0.825, "ebitda": -48572000, "totalDebt": 29709000, "quickRatio": 1.411, "currentRatio": 1.495, "totalRevenue": 1028000, "debtToEquity": 850.53, "revenuePerShare": 0.036, "returnOnAssets": -0.65573996, "returnOnEquity": -3.91098, "grossProfits": 1028000, "freeCashflow": -15861625, "operatingCashflow": -35496000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -10.93774, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1746724083, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.489258, "regularMarketPrice": 0.7501, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "regularMarketChange": -0.08789998, "regularMarketDayRange": "0.7336 - 0.878", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 272842, "fiftyTwoWeekLowChange": 0.016499996, "fiftyTwoWeekLowChangePercent": 0.022491815, "fiftyTwoWeekRange": "0.7336 - 7.47", "fiftyTwoWeekHighChange": -6.7198997, "fiftyTwoWeekHighChangePercent": -0.899585, "fiftyTwoWeekChangePercent": -87.64012, "earningsTimestamp": 1743451500, "earningsTimestampStart": 1743451500, "earningsTimestampEnd": 1743451500, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.05, "epsForward": -1.01, "epsCurrentYear": -0.85, "priceEpsCurrentYear": -0.8824706, "fiftyDayAverageChange": -0.55346, "fiftyDayAverageChangePercent": -0.42457578, "twoHundredDayAverageChange": -1.17697, "twoHundredDayAverageChangePercent": -0.6107562, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]